Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy.

V Kunzmann; Manfred Smetak; B Kimmel; K Weigang-Koehler; M Goebeler; Josef Birkmann; J Becker; I Schmidt-Wolf; H Einsele; Martin Wilhelm

Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy.

V Kunzmann, Manfred Smetak, B Kimmel, K Weigang-Koehler, M Goebeler, Josef Birkmann, J Becker, I Schmidt-Wolf, H Einsele, Martin Wilhelm

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

1 Citation (Web of Science)

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	29
Issue number	15
Publication status	Published - 2011

Cite this

Kunzmann, V., Smetak, M., Kimmel, B., Weigang-Koehler, K., Goebeler, M., Birkmann, J., Becker, J., Schmidt-Wolf, I., Einsele, H., & Wilhelm, M. (2011). Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy. JOURNAL OF CLINICAL ONCOLOGY , 29(15).

Kunzmann, V ; Smetak, Manfred ; Kimmel, B et al. / Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy. In: JOURNAL OF CLINICAL ONCOLOGY 2011 ; Vol. 29, No. 15.

@article{3485e6000c8145b38739bd7cd6b03dc5,

title = "Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy.",

author = "V Kunzmann and Manfred Smetak and B Kimmel and K Weigang-Koehler and M Goebeler and Josef Birkmann and J Becker and I Schmidt-Wolf and H Einsele and Martin Wilhelm",

year = "2011",

language = "English",

volume = "29",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "15",

}

Kunzmann, V, Smetak, M, Kimmel, B, Weigang-Koehler, K, Goebeler, M, Birkmann, J, Becker, J, Schmidt-Wolf, I, Einsele, H & Wilhelm, M 2011, 'Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy.', JOURNAL OF CLINICAL ONCOLOGY , vol. 29, no. 15.

Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy. / Kunzmann, V; Smetak, Manfred; Kimmel, B et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 29, No. 15, 2011.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy.

AU - Kunzmann, V

AU - Smetak, Manfred

AU - Kimmel, B

AU - Weigang-Koehler, K

AU - Goebeler, M

AU - Birkmann, Josef

AU - Becker, J

AU - Schmidt-Wolf, I

AU - Einsele, H

AU - Wilhelm, Martin

PY - 2011

Y1 - 2011

M3 - Abstract (Journal)

SN - 0732-183X

VL - 29

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 15

ER -

Kunzmann V, Smetak M, Kimmel B, Weigang-Koehler K, Goebeler M, Birkmann J et al. Pro-versus antitumor effects of bisphosphonate-activated gamma delta T cells in cancer immunotherapy. JOURNAL OF CLINICAL ONCOLOGY . 2011;29(15).